Erol Veznedaroglu, MD, is the newly appointed director of the Drexel Neurosciences Institute.
“The Drexel Neurosciences Institute seeks to advance the understanding of neurological function, disorders and treatment through interdisciplinary research,” said Daniel Schidlow, MD, dean, Drexel University College of Medicine.
PHILADELPHIA (February 5, 2015) (PRWEB) February 05, 2015
Drexel University College of Medicine is pleased to announce the launch of the Drexel Neurosciences Institute, an innovative collaboration of Drexel’s College of Medicine and Global Neurosciences Institute, LLC (GNI). The Drexel Neurosciences Institute, which will be led by prominent neurosurgeon Erol Veznedaroglu, MD, will serve as the focal point of an integrated approach to neuroscience-related clinical care, education and interdisciplinary research. Drexel’s primary teaching hospital, Hahnemann University Hospital, will be a clinical affiliate of the Institute.
The Drexel Neurosciences Institute will harness the expertise of Drexel Medicine neurologists and researchers, who provide outstanding and groundbreaking care in areas such as Alzheimer’s disease and related dementias, ALS, and chronic pain, combined with the clinical expertise of GNI neurosurgeons, who are among an elite group of dual-trained vascular neurosurgeons able to perform conventional neurosurgery as well as minimally invasive endovascular neurosurgery. The institute will offer patients access to participation in important neuroscience clinical trials.
“In addition to providing advanced neuroscience care for patients, the Drexel Neurosciences Institute seeks to advance the understanding of neurological function, disorders and treatment through interdisciplinary research,” said Daniel V. Schidlow, MD, Annenberg Dean and senior vice president of medical affairs at Drexel University College of Medicine. “It will also enrich our medical and biomedical education programs with the goal of expanding the frontiers of science, technology and healthcare delivery.”
The institute, which launches March 15, 2015, will be led by Erol Veznedaroglu, MD, one of the most experienced cerebrovascular neurosurgeons in the country. Dr. Vez, as he is known, is chairman of GNI, a consortium of some of the nation’s most experienced neurosurgeons, specializing in comprehensive care including vascular, tumor, spine and functional neurosurgery. GNI neurosurgeons joined together to bring the highest level of neurosciences treatment and research to patients in New Jersey and Pennsylvania. Dr. Vez is also the founder of the Capital Institute for Neurosciences at Capital Health. He previously served as director of the Division of Cerebrovascular and Endovascular Neurosurgery at Thomas Jefferson Hospital.
“I am thrilled to be joining Drexel University’s College of Medicine with its rich history of academic medical excellence. Dean Schidlow and his entire team embraced the concept of a comprehensive academic neurosciences institute which will be the first of its kind. Bringing together one comprehensive center where patients are seen by a collaborative team is the future of sophisticated neuroscience care,” said Veznedaroglu, the newly appointed director of the Drexel Neurosciences Institute.
Michael Halter, chief executive officer of Hahnemann University Hospital, added, “The relationship with Drexel Neurosciences Institute and GNI will enhance Hahnemann’s neurosurgical clinical capabilities and offer our patients the region’s foremost specialized care in vascular, tumor, spine, and functional neurosurgery.”
###
About Drexel University College of Medicine
Drexel University College of Medicine has established some of the most highly innovative and rigorous academic programs available today, incorporating the University’s expertise in engineering and technology into traditional medical training. The College of Medicine is home to one of the nation’s leading centers for spinal cord research; one of the foremost centers for malaria study; and a highly regarded HIV/AIDS program with extensive NIH-funded research in prevention and therapeutic interventions. Drexel University College of Medicine has been designated a Vanguard National Center of Excellence in Women’s Health by the U.S. Department of Health & Human Services, and is highly respected in numerous other specialties including cardiology and pain management. Visit http://www.drexelmed.edu for more information. Follow Drexel University College of Medicine on Facebook, YouTube, Twitter and Instagram.
About Global Neurosciences Institute
Global Neurosciences Institute (GNI) brings together some of the nation’s most experienced neurosurgeons specializing in vascular, tumor, spine and functional neurosurgery. Its mission is to provide the highest level of neuroscience treatment and research to patients in New Jersey and Pennsylvania. GNI’s chairman, Erol Veznedaroglu, MD, serves as Director of Drexel Neurosciences Institute, a unique academic institute serving as the focal point of an integrated approach to neuroscience-related clinical care, education and interdisciplinary research. Clinically, GNI is establishing neuroscience institutes at select partner healthcare systems to provide treatment for time-sensitive neurologic emergencies, including interventions for stroke and aneurysm, as well as diseases and injuries of the brain and spine. GNI’s experienced physician consortium also provides comprehensive pain management and treatment for Alzheimer’s disease, Parkinson’s disease, epilepsy, headache, pediatric neurology and autism. GNI physicians provide their patients with access to cutting edge trials evaluating the latest neurosciences treatments and interventions.
About Hahnemann University Hospital
Hahnemann University Hospital is a 496-bed academic medical center at Broad and Vine Streets in Philadelphia, Pa. The hospital is a tertiary care institution that specializes in cardiac services, heart failure, OB/GYN, orthopedics, medical, surgical and radiation oncology, bone marrow transplantation, renal dialysis and kidney/pancreas/liver transplantation. In 2009, Hahnemann earned Magnet® designation by the American Nurses Credentialing Center (ANCC) Magnet Recognition Program® and received redesignation in 2015. Hahnemann is recognized by the American Heart Association as a leader in stroke and heart failure treatments. U.S. News and World Report’s 2014-15 “Best Hospital’s” report named Hahnemann among the top 50 Best Hospitals in the nation for nephrology, and ranked 12 medical specialties as “high performing.” The hospital performed one of the city’s first kidney transplants in 1963 and one of the first bone marrow transplants in 1976. Hahnemann became Philadelphia’s first Level I Regional Resource Trauma Center for adults in 1986. Hahnemann is proud to be the first hospital in Philadelphia to join with The Wellness Community of Philadelphia to offer onsite support and education services to cancer patients and their families. Hahnemann is fully accredited by the Joint Commission on the Accreditation of Healthcare Organizations, the nation’s oldest and largest hospital accreditation agency. An affiliate of Drexel University College of Medicine, Hahnemann University Hospital is part of Tenet Pennsylvania, which also includes St. Christopher’s Hospital for Children.